Description
FOR ANIMAL USE ONLY
ROTAVEC® CORONA
Reg. No. G2955 (Act 36/1947)
Namibia Reg. No. V07/24.4/747 [NS0]
Emulsion for injection
Only for use by or under the supervision of persons registered in terms of, or authorised in terms of, Section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, 1982 (Act 19 of 1982).
INDICATIONS
For the active immunisation of pregnant cows and heifers to raise antibodies against E. coli adhesins F5 (K99) and F41, rotavirus and coronavirus. While calves are fed colostrum from vaccinated cows during the first 2 to 4 weeks of life, these antibodies have been demonstrated to:
- Reduce the severity of diarrhoea caused by E. coli.
- Reduce the incidence of scours caused by rotavirus.
- Reduce the shedding of virus by calves infected with rotavirus or coronavirus.
Onset of Immunity: Passive protection against all active substances will commence from the start of colostrum feeding
Duration of Immunity: In calves artificially fed with colostrum, protection will continue until colostrum feeding ceases. In naturally suckled calves, protection against rotavirus will persist for at least 7 days and against coronavirus for at least 14 days.
COMPOSITION
Each 2 mℓ contains:
Bovine rotavirus strain UK-Compton, serotype G6 P5 (inactivated) ≥ 874 U1
Bovine coronavirus, strain Mebus (inactivated) ≥ 340 U1
E. coli strain CN7985 (K99+:F41+) ≥ 560 U1
Adjuvant: aluminium hydroxide and light mineral oil/emulsifier.
Preservative: thiomersal ≤ 0,069 mg
1 Units as determined in the in-vitro potency tests
